Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia

By                      

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3948-3954

Spandidos Publications

Access to resources Recommend Favorite

Palliative chemotherapy followed by methylation inhibitor in high-risk acute myeloid leukemia: An in vitro and clinical study

By                      

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1139-1144

Science Publishers

Access to resources Recommend Favorite

Development of treatment and clinical results in childhood acute myeloid leukemia in Slovenia in the period from 1991 to 2010

By Velikonja Orjana   Stefanović Milica   Kitanovski Lidija   Podgornik Helena   Jazbec Janez  

memo - Magazine of European Medical Oncology, Vol. 7, Iss. 1, 2014-02 ,pp. : 56-62

Springer Publishing Company

Access to resources Recommend Favorite

Clinical study of Mito-FLAG regimen in treatment of relapsed acute myeloid leukemia

By              

Experimental and Therapeutic Medicine, Vol. 5, Iss. 3, 2013-01 ,pp. : 982-986

Spandidos Publications

Access to resources Recommend Favorite

Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients

By                    

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 181-187

Spandidos Publications

Access to resources Recommend Favorite